Gallium dotatate ga-68 - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for gallium dotatate ga-68 and what is the scope of patent protection?
Gallium dotatate ga-68
is the generic ingredient in one branded drug marketed by Aaa Usa Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Gallium dotatate ga-68 has thirty-two patent family members in nineteen countries.
One supplier is listed for this compound.
Summary for gallium dotatate ga-68
International Patents: | 32 |
US Patents: | 1 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 16 |
DailyMed Link: | gallium dotatate ga-68 at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for gallium dotatate ga-68
Generic Entry Date for gallium dotatate ga-68*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for gallium dotatate ga-68
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
Peking Union Medical College Hospital | Early Phase 1 |
First Affiliated Hospital of Fujian Medical University | Early Phase 1 |
US Patents and Regulatory Information for gallium dotatate ga-68
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aaa Usa Inc | NETSPOT | gallium dotatate ga-68 | POWDER;INTRAVENOUS | 208547-001 | Jun 1, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for gallium dotatate ga-68
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2844145 | PROCEDE POUR LA PREPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA) | ⤷ Sign Up |
India | 1897CHN2014 | ⤷ Sign Up | |
European Patent Office | 2955168 | PROCÉDÉ POUR LA PRÉPARATION DE COMPLEXES DE 68GA (PROCESS FOR THE PREPARATION OF COMPLEXES OF 68GA) | ⤷ Sign Up |
Brazil | 112014003336 | processo para a preparação de complexos de 68ga | ⤷ Sign Up |
China | 103889930 | Process for the preparation of complexes of 68ga. | ⤷ Sign Up |
Israel | 230904 | תהליך להכנת קומפלקסים של גאליום -68 (Process for the preparation of complexes of 68ga) | ⤷ Sign Up |
Poland | 2742017 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |